Cargando…

A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay

BACKGROUND: Since 2020 SARS-CoV-2 spreads pandemically, infecting more than 119 million people, causing >2·6 million fatalities. Symptoms of SARS-CoV-2 infection vary greatly, ranging from asymptomatic to fatal. Different populations react differently to the disease, making it very hard to track...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beyerl, Jessica, Rubio-Acero, Raquel, Castelletti, Noemi, Paunovic, Ivana, Kroidl, Inge, Khan, Zohaib N., Bakuli, Abhishek, Tautz, Andreas, Oft, Judith, Hoelscher, Michael, Wieser, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320407/ https://www.ncbi.nlm.nih.gov/pubmed/34333234 http://dx.doi.org/10.1016/j.ebiom.2021.103502

Ejemplares similares

Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
por: Ahmed, Mohamed I. M., et al.
Publicado: (2023)

Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich - One year of experience
por: Rubio-Acero, Raquel, et al.
Publicado: (2021)

The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases
por: Puchinger, Kerstin, et al.
Publicado: (2022)

The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
por: Le Gleut, Ronan, et al.
Publicado: (2023)

In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
por: Rubio-Acero, Raquel, et al.
Publicado: (2021)

Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
por: Riester, Elena, et al.
Publicado: (2021)

Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay
por: Vauloup-Fellous, C., et al.
Publicado: (2014)

Analysis of SARS-CoV-2 antibodies from dried blood spot samples with the Roche Elecsys Immunochemistry method
por: Fontaine, Elizabeth, et al.
Publicado: (2021)

Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay
por: Mulchandani, Ranya, et al.
Publicado: (2021)

Multicentre evaluation of the Roche Elecsys® Active B(12) (holotranscobalamin) electro-chemiluminescence immunoassay
por: Heil, Sandra G, et al.
Publicado: (2019)

Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
por: Kroidl, Inge, et al.
Publicado: (2023)

The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
por: Reinkemeyer, Christina, et al.
Publicado: (2023)

Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
por: Aijaz, Javeria, et al.
Publicado: (2023)

Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications
por: Sulaeman, Hasan, et al.
Publicado: (2023)

From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
por: Radon, Katja, et al.
Publicado: (2021)

Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay
por: Tang, Nga-Yeung, et al.
Publicado: (2020)

The Androstenedione Roche Elecsys immunoassay has superior comparability to the LC-MS/MS assay than the Siemens Immulite immunoassay
por: Wei, Ruhan, et al.
Publicado: (2022)

Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment
por: Takei, Satomi, et al.
Publicado: (2022)

Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
por: Nakai, Miku, et al.
Publicado: (2023)

Comparison of the Automated Fluorescent Immunoassay System With Roche Elecsys and Beckman Coulter Access 2 Assays for Anti-Müllerian Hormone Measurement
por: Han, Aera, et al.
Publicado: (2022)

Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian Region
por: Lau, Chin Shern, et al.
Publicado: (2022)

AMHconverter: an online tool for converting results between the different anti-Müllerian hormone assays of Roche Elecsys(®), Beckman Access, and Kangrun
por: Xu, Huiyu, et al.
Publicado: (2023)

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
por: Kittel, Maximilian, et al.
Publicado: (2021)

Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
por: Ahmed, Mohamed Ibraheem Mahmoud, et al.
Publicado: (2022)

Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
por: Brand, Isabel, et al.
Publicado: (2021)

Cross-Method Comparison of Serum Androstenedione Measurement Using Three Different Assays: The Siemens Immulite Immunoassay, the Roche Elecsys Immunoassay, and an LC/MS-MS Assay
por: Wei, Ruhan, et al.
Publicado: (2021)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
por: Park, Joonhong, et al.
Publicado: (2021)

Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
por: Kroidl, Inge, et al.
Publicado: (2021)

Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
por: Chan, Henry L Y, et al.
Publicado: (2022)

Paediatric reference intervals for plasma anti-Müllerian hormone: comparison of data from the Roche Elecsys assay and the Beckman Coulter Access assay using the same cohort of samples
por: Yates, Allen P, et al.
Publicado: (2019)

Analytical performance evaluation of the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays on the cobas e411 analyzer
por: Sasano, Maki, et al.
Publicado: (2017)

Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
por: Eser, Tabea M., et al.
Publicado: (2023)

Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe
por: Fryatt, Arun, et al.
Publicado: (2021)

Roch : novela hagiográfica /
por: Hernández, Luisa Josefina
Publicado: (2008)

Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys(®) Immunoassay in the S Protein Vaccination Era
por: Delgado, Juan Francisco, et al.
Publicado: (2023)

Kevin Roche /
por: Roche, Kevin
Publicado: (1985)

Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich
por: Pritsch, Michael, et al.
Publicado: (2021)

Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
por: Inés, Riberi María, et al.
Publicado: (2022)

Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities
por: Gudina, Esayas Kebede, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9e6amj2mkiqoqj9gue7ttsvrl9